CHADI CALARGE to Follow-Up Studies
This is a "connection" page, showing publications CHADI CALARGE has written about Follow-Up Studies.
Connection Strength
0.510
-
Predictors of depressive symptom trajectories in a prospective follow-up of late adolescents. Psychol Med. 2020 10; 50(13):2283-2288.
Score: 0.087
-
Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys. J Pediatr. 2018 10; 201:245-251.
Score: 0.080
-
Polyunsaturated fatty acid composition and childhood adversity: Independent correlates of depressive symptom persistence. Psychiatry Res. 2017 10; 256:305-311.
Score: 0.075
-
Body Composition in Adolescents During Treatment With Selective Serotonin Reuptake Inhibitors. Pediatrics. 2017 Jul; 140(1).
Score: 0.075
-
Iron homeostasis during risperidone treatment in children and adolescents. J Clin Psychiatry. 2015 Nov; 76(11):1500-5.
Score: 0.067
-
Rapid adipose deposition with mood disorders. Ann Clin Psychiatry. 2015 Nov; 27(4):283-8.
Score: 0.067
-
Cardiometabolic outcomes in children and adolescents following discontinuation of long-term risperidone treatment. J Child Adolesc Psychopharmacol. 2014 Apr; 24(3):120-9.
Score: 0.060